These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7289389)

  • 21. [Medical and surgical therapeutic indications in peripheral arterial obliterations caused by arteriosclerosis].
    Fontaine R; Fontaine JL
    Minerva Med; 1967 Dec; 58(101):4648-55. PubMed ID: 6082165
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 23. [Distribution of obliterating atherosclerosis of the arteries of the lower extremities and its relationship to ischemic heart disease].
    Dokuchaeva EA
    Kardiologiia; 1974 Feb; 14(2):131-6. PubMed ID: 4825006
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the significance of arteriosclerosis in the etiology of cerebral vascular occlusions].
    Bankl H
    Wien Klin Wochenschr; 1969 Jun; 81(24):447-9. PubMed ID: 5361782
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].
    Dudaev VA; Gorin VV; Shingireĭ MV; Kliuchnikova ZhI; Diukov IV
    Kardiologiia; 1984 Jun; 24(6):76-9. PubMed ID: 6748497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic therapy for atherosclerotic intracranial arterial stenosis.
    Chimowitz MI
    Adv Neurol; 2003; 92():271-4. PubMed ID: 12760193
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current status of the study on the integration of traditional Chinese medicine with Western medicine in the treatment of arteriosclerosis obliterans].
    Chen P; Shang D
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Feb; 18(2):122-4. PubMed ID: 11367643
    [No Abstract]   [Full Text] [Related]  

  • 28. Thromboembolism and antithrombotic therapy in cerebrovascular disease.
    Sherman DG; Hart RG
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):88B-97B. PubMed ID: 3537073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An assessment of the efficacy of intravenous monotherapy with the preparation solcoseryl in patients with arteriosclerosis obliterans of the vessels of the lower extremities].
    Luk'ianov IuV; Shlomin VV; Sokurenko GIu; Didenko IuP; Orlov NN; Kondrat'ev VM; Batalin IV
    Vestn Khir Im I I Grek; 2000; 159(3):81-4. PubMed ID: 10983350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience with the use of papaverolina in patients with arterial diseases].
    Patrignani S; Graziani A; Ranieri A; Russo O
    Clin Ter; 1981 Jun; 97(5):495-519. PubMed ID: 7273660
    [No Abstract]   [Full Text] [Related]  

  • 31. The mechanisms of the anticoagulant and antithrombotic medications used in the treatment of acute coronary syndrome (ACS).
    Albritton S; Shuler L; Schatz K
    Crit Care Nurse; 2001 Aug; 21(4):75-7. PubMed ID: 11858692
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinico-functional characteristics of patients with arteriosclerosis obliterans of the lower extremities and painless myocardial ischemia].
    Volkov VS; Beliaeva GS
    Kardiologiia; 1990 Jul; 30(7):74-6. PubMed ID: 2232470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J; Lysakowska-Sernicka K; Gajewska A; Bilińska-Nigot B; Ostrowski K; Semenicki K
    Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
    [No Abstract]   [Full Text] [Related]  

  • 35. Coronary (ischaemic) heart disease in patients with arteriosclerosis obliterans.
    SELVAAG O
    Acta Med Scand Suppl; 1956; 319():59-67. PubMed ID: 13394194
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 37. [Arteriosclerosis: a challenge for the surgeon. Prevention and postoperative care (author's transl)].
    Rau G
    Langenbecks Arch Chir; 1975 Nov; 339():175-85. PubMed ID: 1207298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Consensus antithrombotic prophylaxis of vascular incidents in patients with manifest atherosclerotic vascular diseases. Central Guidance Organization for Peer Review].
    Tijssen JG
    Ned Tijdschr Geneeskd; 1998 Jan; 142(2):83-8. PubMed ID: 9556999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contributions on the disease picture of arteriosclerosis obliterans on the basis of observations in 1071 patients].
    Bugár-Mészáros K; Bereczky M
    Z Kreislaufforsch; 1966 Jul; 55(7):706-16. PubMed ID: 5992400
    [No Abstract]   [Full Text] [Related]  

  • 40. A survey of amputations for degenerative vascular disease.
    Little JM; Petritsi-Jones D; Zylstra P; Williams R; Kerr C
    Med J Aust; 1973 Feb; 1(7):329-34. PubMed ID: 4699026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.